These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 26719217)

  • 1. Cyclin-Dependent Kinases as Coregulators of Inflammatory Gene Expression.
    Schmitz ML; Kracht M
    Trends Pharmacol Sci; 2016 Feb; 37(2):101-113. PubMed ID: 26719217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoclast differentiation by RANKL requires NF-kappaB-mediated downregulation of cyclin-dependent kinase 6 (Cdk6).
    Ogasawara T; Katagiri M; Yamamoto A; Hoshi K; Takato T; Nakamura K; Tanaka S; Okayama H; Kawaguchi H
    J Bone Miner Res; 2004 Jul; 19(7):1128-36. PubMed ID: 15176996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function.
    Foster JS; Henley DC; Bukovsky A; Seth P; Wimalasena J
    Mol Cell Biol; 2001 Feb; 21(3):794-810. PubMed ID: 11154267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural analysis of the inhibition of Cdk4 and Cdk6 by p16(INK4a) through molecular dynamics simulations.
    Villacañas O; Pérez JJ; Rubio-Martínez J
    J Biomol Struct Dyn; 2002 Dec; 20(3):347-58. PubMed ID: 12437373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formation of p27-CDK complexes during the human mitotic cell cycle.
    Soos TJ; Kiyokawa H; Yan JS; Rubin MS; Giordano A; DeBlasio A; Bottega S; Wong B; Mendelsohn J; Koff A
    Cell Growth Differ; 1996 Feb; 7(2):135-46. PubMed ID: 8822197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional cyclin-dependent kinases as the mediators of inflammation-a review.
    Sundar V; Vimal S; Sai Mithlesh MS; Dutta A; Tamizhselvi R; Manickam V
    Gene; 2021 Feb; 769():145200. PubMed ID: 33031895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of the G1/S transition.
    Reed SI
    Cancer Surv; 1997; 29():7-23. PubMed ID: 9338094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
    Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
    Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanism of cell cycle progression induced by the oncogene product Tax of human T-cell leukemia virus type I.
    Iwanaga R; Ohtani K; Hayashi T; Nakamura M
    Oncogene; 2001 Apr; 20(17):2055-67. PubMed ID: 11360190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of cyclinT/Cdk9 complex in basal and regulated transcription (review).
    Napolitano G; Majello B; Lania L
    Int J Oncol; 2002 Jul; 21(1):171-7. PubMed ID: 12063565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of cyclins and cdks throughout murine carcinogenesis.
    Yerly-Motta V; Contassot E; Pavy JJ; Tiberghien P; Hervé P
    Cell Mol Biol (Noisy-le-grand); 1999 Dec; 45(8):1217-28. PubMed ID: 10643971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-beta in cells lacking the CDK inhibitor p15.
    Iavarone A; Massagué J
    Nature; 1997 May; 387(6631):417-22. PubMed ID: 9163429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of E2F transcription by cyclin E-Cdk2 kinase mediated through p300/CBP co-activators.
    Morris L; Allen KE; La Thangue NB
    Nat Cell Biol; 2000 Apr; 2(4):232-9. PubMed ID: 10783242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin-dependent kinases regulate the antiproliferative function of Smads.
    Matsuura I; Denissova NG; Wang G; He D; Long J; Liu F
    Nature; 2004 Jul; 430(6996):226-31. PubMed ID: 15241418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of phosphatidylinositol 3-kinase and c-Jun-N-terminal kinase cascades enhances NF-kappaB-dependent gene transcription in BCG-stimulated macrophages through promotion of p65/p300 binding.
    Darieva Z; Lasunskaia EB; Campos MN; Kipnis TL; Da Silva WD
    J Leukoc Biol; 2004 Apr; 75(4):689-97. PubMed ID: 14742634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The roles and therapeutic potential of cyclin-dependent kinases (CDKs) in sarcoma.
    Liao Y; Feng Y; Shen J; Hornicek FJ; Duan Z
    Cancer Metastasis Rev; 2016 Jun; 35(2):151-63. PubMed ID: 26669603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of G1 cell cycle regulators in rat liver upon repeated exposure to thioacetamide.
    Kim KT; Han SY; Jeong JS
    Korean J Hepatol; 2007 Mar; 13(1):81-90. PubMed ID: 17380078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of cyclin-dependent kinase 6, but not cyclin-dependent kinase 4, alters morphology of cultured mouse astrocytes.
    Ericson KK; Krull D; Slomiany P; Grossel MJ
    Mol Cancer Res; 2003 Jul; 1(9):654-64. PubMed ID: 12861051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticarcinogenic effect of a flavonoid antioxidant, silymarin, in human breast cancer cells MDA-MB 468: induction of G1 arrest through an increase in Cip1/p21 concomitant with a decrease in kinase activity of cyclin-dependent kinases and associated cyclins.
    Zi X; Feyes DK; Agarwal R
    Clin Cancer Res; 1998 Apr; 4(4):1055-64. PubMed ID: 9563902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming activity of Fbxo7 is mediated specifically through regulation of cyclin D/cdk6.
    Laman H; Funes JM; Ye H; Henderson S; Galinanes-Garcia L; Hara E; Knowles P; McDonald N; Boshoff C
    EMBO J; 2005 Sep; 24(17):3104-16. PubMed ID: 16096642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.